Skadden, Arps, Slate, Meagher & Flom LLP's team of German and US lawyers is an experienced advisor on matters entailing a strong US component, such as US IPOs and private placements under Rule 144A, although the practice also has a geographical focus on the DACH region. Issuers and syndicate banks frequently make use of this offering; the practice recently assisted them with capital increases, takeovers and share issuances in addition to (planned) IPOs and dual listings; practice head Stephan Hutter (capital market transactions, M&A, corporate governance and compliance) predominantly leads on these matters.
Legal 500 redaktioneller Kommentar
- Profil
Kernmandanten
- Commerzbank
- Deutsche Bank
- Fresenius
- HSBC
- Morgan Stanley
- MorphoSys
- ONWARD Medical
- SIGNA Sports United
- UBS
- UniCredit
Highlight-Mandate
- Advising MorphoSys AG on the acquisition of Morphosys by Novartis for approximately €2.7 billion and on a cash capital increase with gross proceeds of approximately €102.7 million.
- Advising the Management Board and Supervisory Board of Fresenius on the exit from Austrian and international business activities of Vamed Group (including advice on refinancing and restructuring).
- Advising ONWARD® Medical on a €20 million cash capital increase.
Anwält*innen
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Praxisleitung
Stephan Hutter
Weitere Kernanwält*innen
Lukas Greilich; Caspar Schmelzer